NeuroproteXeon, Inc.   Report issue

For profit Phase 3
Founded: Orchard Park NY United States (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2017
NCT03176186
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now